Lars Erik Vølund Kristensen

Lars Erik Vølund Kristensen

Clinical Professor


  1. 2023
  2. Published

    Cytokine Signatures in Psoriatic Arthritis Patients Indicate Different Phenotypic Traits Comparing Responders and Non-Responders of IL-17A and TNFα Inhibitors

    Skougaard, M., Ditlev, S. B., Søndergaard, M. F. & Kristensen, Lars Erik Vølund, 2023, In: International Journal of Molecular Sciences. 24, 7, 16 p., 6343.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2022
  4. Published

    Agreement between self-reported and observed functioning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia, and the influence of pain and fatigue: a cross-sectional study

    Amris, K., Bandak, Elisabeth Ann, Kristensen, Lars Erik Vølund & Wæhrens, E. E., 2022, In: Scandinavian Journal of Rheumatology. 51, 6, p. 452-460 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Exercise and education versus saline injections for knee osteoarthritis: a randomised controlled equivalence trial

    Bandak, Elisabeth Ann, Christensen, R., Overgaard, A., Kristensen, Lars Erik Vølund, Ellegaard, K., Guldberg-Møller, J., Bartholdy, C., Hunter, D. J., Altman, R., Bliddal, Henning & Henriksen, Marius, 2022, In: Annals of the Rheumatic Diseases. 81, 4, p. 537-543 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Triage strategies based on c-reactive protein levels and sars-cov-2 tests among individuals referred with suspected covid-19: A prospective cohort study

    Boyesen, E. O., Balsby, I. M., Henriksen, Marius, Christensen, R., Rasmussen, J. H., Nielsen, F. E., Nygaard, H., Friis-Hansen, Lennart Jan, Nielsen, S. D., Thudium, R. F., Porsberg, C., Kristensen, Lars Erik Vølund & Bliddal, Henning, 2022, In: Journal of Clinical Medicine. 11, 1, 201.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Vitamin D Concentrations at Birth and the Risk of Rheumatoid Arthritis in Early Adulthood: A Danish Population-Based Case-Cohort Study

    Cardoso, I., Specht, I. O., Thorsteinsdottir, F., Thorbek, M. J., Keller, A., Stougård, Maria, Cohen, A. S., Händel, M. N., Kristensen, Lars Erik Vølund & Heitmann, Berit, 2022, In: Nutrients. 14, 3, 11 p., 447.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Identifying and understanding disease burden in patients with inflammatory bowel disease

    Christensen, K. R., Ainsworth, M. A., Skougaard, M., Steenholdt, Casper, Buhl, S., Brynskov, J., Kristensen, Lars Erik Vølund & Jørgensen, T. S., 2022, In: BMJ Open Gastroenterology. 9, 1, 11 p., 000994.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3

    Egeberg, Alexander, Kristensen, Lars Erik Vølund, Vender, R., Zaheri, S., El Baou, C., Gallo, G., Riedl, E. & Schuster, C., 2022, In: Acta Dermato-Venereologica. 102, 4 p., adv00787.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1

    Kristensen, Lars Erik Vølund, Soliman, A. M., Papp, K., Merola, J. F., Barcomb, L., Wang, Z., Eldred, A. & Behrens, F., 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 5, p. e389-e392

    Research output: Contribution to journalLetterResearchpeer-review

  11. Published

    The effect of risankizumab on achieving minimal clinically important differences in patient‐reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2

    Kristensen, Lars Erik Vølund, Soliman, A. M., Papp, K., Barcomb, L., Eldred, A. & Östör, A., 1 Nov 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 11, p. 2120-2129 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial

    Kristensen, Lars Erik Vølund, Keiserman, M., Papp, K., McCasland, L., White, D., Lu, W., Wang, Z., Soliman, A. M., Eldred, A., Barcomb, L. & Behrens, F., 2022, In: Annals of the Rheumatic Diseases. 81, 2, p. 225-231 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next

ID: 164256855